|
|
|
| Recovery effect of desogestrel and ethinylestradiol tablets on endometrum of women with medical abortion after uterine curettage |
| Ganzi People's Hospital, Sichuan Province, 626000 |
|
|
|
|
Abstract To investigate the effect of desogestrel and ethinylestradiol tablets on endometrial repair of women with medical abortion after uterine curettage. Methods: 100 women with medical abortion after uterine curettage were randomly divided into two groups (50 cases in each group). The women in observation group were given oral deoxypregnene ethinylestradiol tablets, while the women in control group were not given treatment. Vaginal bleeding volume, uterine involution situation, and complications rate of women were compared between the two groups. Results: Two weeks after abortion, the endometrial thickness (3.20±0.74mm) of women in the observation group was significant higher than that (2.71±0.17mm) of women in the control group, but the uterine transverse diameter and longitudinal diameter of women in the observation group were significant lower (P<0.05). The time of vaginal bleeding after operation of women in both groups was less than 10 days, but the proportion of women with vaginal bleeding time ≤5 days in the observation group (86.0%) was significant higher than that (50.0%) of women in the control group, the proportion of women with vaginal bleeding volume less than menstruation in the observation group (80.0%) was significant higher than that (60.0%) of women in the control group, the proportion of women with the time of menstruation recovery ＜30d in the observation group (92.0%) was significant higher than that (72.0%) of women in the control group, and the total incidence of postoperative complications of women in the observation group (4.0%) was significant lower than that (26.0%) of women in the control group (all P<0.05). Conclusion: Oral deoxypregnene ethinylestradiol tablets after uterine curettage can promote endometrial repair, shorten the time of vaginal bleeding, regulate menstrual cycle, and reduce the risk of uterine adhesions.
|
|
|
|
|
|
|
|
|
